Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

OptiBiotix Health (OPTI) Price & Analysis

OPTI Stock Chart & Stats

GBX 5.80GBX 0.00(0.00%)
At close: 4:00 PM EDT
GBX 6GBX 6.53 Aug17 Aug1 Sep14 Sep28 Sep12 Oct26 Oct
Day’s Range
GBX 5.70 - GBX 5.79
52-Week Range
GBX 4.50 - GBX 9.00
Previous Close
GBX 5.80
Volume
2,352
Average Volume (3M)
59.19K
Market Cap
GBP 5.99M
Enterprise Value
GBP 5.62M
Total Cash (Recent Filing)
GBP 989.00K
Total Debt (Recent Filing)
GBP 0
Price to Earnings (P/E)
―
Beta
0.43
Next Earnings
Jul 01, 2027
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth

The sharp increase in 2025 revenue indicates stronger commercial traction for the company’s probiotic and microbiome products. If partner-led launches and customer demand continue, this growth can provide greater operating leverage and support broader market penetration over the next several quarters.

Improving Gross Margin

The substantial gross-margin improvement suggests better unit economics and a more attractive contribution from recent revenue. Maintaining this level would improve the company’s ability to convert commercial growth into cash and could help narrow losses as revenue expands.

Debt-Free Balance Sheet

The absence of reported debt reduces refinancing exposure and interest-rate risk, giving OptiBiotix greater flexibility while it develops and commercialises its intellectual property. A conservatively levered balance sheet can also make future strategic funding decisions less constrained by creditors.

Bears Say

Persistent And Widening Losses

Continuing losses show that revenue growth has not yet translated into a viable earnings model. With operating costs still scaling faster than revenue, the company may need sustained growth or further cost discipline before its commercial progress produces durable profitability.

Ongoing Operating Cash Burn

Persistent negative operating cash flow means the business is not yet self-funding its activities, despite recent revenue growth. Continued cash burn can require external financing or tighter spending, potentially limiting investment capacity and increasing funding pressure if losses persist.

Declining Equity And Negative Returns

Falling equity and deeply negative returns indicate that cumulative losses are eroding the capital base rather than generating value for shareholders. If this pattern continues, future financing could become more dilutive and the company’s financial resilience may weaken despite having no reported debt.

OptiBiotix Health News

OPTI FAQ

What was OptiBiotix Health’s price range in the past 12 months?
OptiBiotix Health lowest share price was 4.50 p and its highest was 9.00 p in the past 12 months.
What is OptiBiotix Health’s market cap?
OptiBiotix Health’s market cap is £5.99M.
When is OptiBiotix Health’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were OptiBiotix Health’s earnings last quarter?
OptiBiotix Health released its earnings results on Sep 17, 2026. The company reported -0.015 p earnings per share for the quarter.
Is OptiBiotix Health overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does OptiBiotix Health pay dividends?
OptiBiotix Health does not currently pay dividends.
What is OptiBiotix Health’s EPS estimate?
OptiBiotix Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OptiBiotix Health have?
OptiBiotix Health has 103,300,300 shares outstanding.
What happened to OptiBiotix Health’s price movement after its last earnings report?
OptiBiotix Health reported an EPS of -0.015 p in its last earnings report. Following the earnings report the stock price went down -9.848%.
Which hedge fund is a major shareholder of OptiBiotix Health?
Currently, no hedge funds are holding shares in GB:OPTI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology